Custom Search
Alteplase News
Early lytic treatment of massive pulmonary embolism improves patient outcome: Clot-dissolving therapy with alteplase plus unfractionated heparin superior to heparin alone, major new trial demonstrates
Administering the clot-dissolving drug alteplase (ActilyseŽ, Boehringer Ingelheim) early in the course of massive pulmonary embolism prevents worsening of the disease, a new clinical trial has shown.
Alteplase Licensed for Catheter Clearance
"The licensing for alteplase has been expanded to include the restoration of function to central venous access devices (CVADs), making the thrombolytic agent the first one to have FDA-approved labeling for this indication since...
Unclog Your Catheter with Alteplase
Genentech, Inc. (1 DNA Way, South San Francisco, CA 94080; Tel: 650/225-1000, Fax: 650/225-8326; Website: www.gene.com) has submitted for review to the U.S. Food and Drug Administration (FDA) a Supplemental Biologic License...
Displaying results 11 to 13 out of 13